Satya Kuchimanchi - CAMP4 THERAPEUTICS Senior Operations

CAMP Stock  USD 4.91  1.16  30.93%   

Executive

Satya Kuchimanchi is Senior Operations of CAMP4 THERAPEUTICS PORATION
Phone(617) 651-8867
Webhttps://www.camp4tx.com

Similar Executives

Showing other executives

EXECUTIVE Age

Richard DriscollKVH Industries
N/A
France TeasdaleTelesat Corp
57
Asit TandonTelesat Corp
N/A
Koen LindeCommScope Holding Co
N/A
David HanoverHarmonic
N/A
Jeffrey GlahnHarmonic
N/A
Pamela GilliesHarmonic
N/A
Charles CheeversCommScope Holding Co
N/A
Ian GrahamHarmonic
63
Michael SchwartzTelesat Corp
60
Tiffany ChangNETGEAR
N/A
Guy AharonovIturan Location and
59
Sam VinciKnowles Cor
N/A
Brian KirkendallDigi International
N/A
Bryan MurrayNETGEAR
49
Michael BondiComtech Telecommunications Corp
51
Justin SchmidDigi International
N/A
Boris KokotovicCommScope Holding Co
N/A
Joia ThompsonADTRAN Inc
N/A
Rich LuhrsComtech Telecommunications Corp
N/A
Shahar SheratzkyIturan Location and
44
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company was incorporated in 1981 and is headquartered in Irvine, California. CalAmp Corp operates under Communication Equipment classification in the United States and is traded on NASDAQ Exchange. It employs 887 people. CAMP4 THERAPEUTICS PORATION (CAMP) is traded on NASDAQ Exchange in USA. It is located in One Kendall Square, Cambridge, MA, United States, 02139 and employs 53 people. CAMP4 THERAPEUTICS is listed under Pharmaceutical Products category by Fama And French industry classification.

CAMP4 THERAPEUTICS Leadership Team

Elected by the shareholders, the CAMP4 THERAPEUTICS's board of directors comprises two types of representatives: CAMP4 THERAPEUTICS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CAMP4. The board's role is to monitor CAMP4 THERAPEUTICS's management team and ensure that shareholders' interests are well served. CAMP4 THERAPEUTICS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CAMP4 THERAPEUTICS's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kelly Gold, Chief Officer
John Partain, Interim Experience
Erik Schulz, Interim Officer
Joshua MandelBrehm, President CEO
Christian Horne, Interim Sales
Brett Jackson, Senior Logistics
Mark Gaydos, Chief Officer
Michael Zachan, Senior Unit
Nathan Lowstuter, Senior Officer
Xiaolian Zhang, Senior Analysis
Caleb Moore, Chief Operations
Maurizio Iperti, President Automotive
Richard Young, Founder Director
David Bumcrot, Chief Research
Daniel Tardiff, VP Discovery
Monica Berkel, Senior President
Michelle Gates, Senior Officer
Chris Adams, President CEO
Leonard MD, Founder
Jeffery Gardner, Independent Director
Richard Scott, Chief VP
Scott Tripp, VP Operations
MD MBA, Chief Officer
Richard Vitelle, CFO, Executive VP, Corporate Secretary and Treasurer
Anand Rau, VP CTO
Jikun Kim, Senior CFO
Satya Kuchimanchi, Senior Operations

CAMP4 Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CAMP4 THERAPEUTICS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.